HHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-dceg; appropriated; automated evaluation of biomarker-stained slides; 09/24/2018-09/23/2023
Ended Awarded Last action
- Contract number
- 75N91018F00070
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,304,455
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $1,304,455.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $25,616 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $434,049 | |
| Funding Only Action | $344,790 | |
| Original award | $500,000 |
About this award
This is a $1,304,455.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the "Automated Evaluation of Biomarker-Stained Slides" and has a period of performance from September 24, 2018 to September 23, 2023. Leidos Biomedical Research is not a small business, and the contract was not set aside. Leidos Biomedical Research has previously performed a variety of research, development, and production services for federal agencies like the NIH, including work in areas like cancer, HIV/AIDS, influenza, COVID-19, and gene therapy research. This contract is associated with Leidos Biomedical Research's role as a Federally Funded Research and Development Center (FFRDC) for the National Cancer Institute, a $6.6 billion indefinite delivery contract that provides a broad range of biomedical research and facilities support services.
Quick answers
Who was awarded contract 75N91018F00070?
75N91018F00070 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.
How much is contract 75N91018F00070 worth?
The government has obligated $1,304,455 on 75N91018F00070.
Is contract 75N91018F00070 an order under another contract?
Yes. 75N91018F00070 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00070 competed?
The extent of competition for 75N91018F00070 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award